IMAC Holdings, Inc.

NasdaqCM BACK

IMAC Holdings, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2024

IMAC Holdings, Inc. EBIT Margin is NA for the Trailing 12 Months (TTM) ending June 30, 2024. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.

IMAC Holdings, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2023 was -171.84%, a -172.87% change year over year.
IMAC Holdings, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2022 was -62.98%, a -16.88% change year over year.
IMAC Holdings, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2021 was -53.88%, a -21.71% change year over year.
IMAC Holdings, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2020 was -44.27%, a 1.15% change year over year.

Key data

Date	EBIT Margin	EPS (Basic)	EPS (Diluted)	Shares (Basic, Weighted)

NasdaqCM: BACK

IMAC Holdings, Inc.

CEO	Ms. Faith Zaslavsky
IPO Date	Feb. 13, 2019
Location	United States
Headquarters	1605 Westgate Circle
Employees	2
Sector	Health Care
Industries Hospitals & Clinics Pharmaceuticals

Description

IMAC Holdings, Inc. owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides physical therapy and spinal decompression, and chiropractic manipulation. The company owns or manages 15 outpatient medical clinics in Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Brentwood, Tennessee.

Key trends

Past 5 years